Dolby Laboratories
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -14.4% | +16.4% | +4.9% | -6.8% | -7.0% | +4.9% | +30.2% | -28.9% | -11.5% | +16.0% | +44.3% | |
| – | – | +23.2% | -1.0% | -3.6% | +4.7% | +6.8% | +24.1% | -8.1% | -31.2% | +22.6% | +12.9% | |
| – | – | -0.1% | -2.5% | +9.0% | +7.5% | +13.1% | +15.1% | +15.3% | -21.4% | +32.7% | +7.3% | |
| – | – | +51.0% | -24.5% | +339.8% | -43.7% | +22.2% | -59.5% | +115.5% | +29.6% | – | – | |
| – | – | +99.9% | +31.3% | +69.3% | -173.0% | – | – | – | – | – | – | |
| – | +147.6% | +13.8% | -52.7% | -18.6% | +33.0% | -39.2% | -21.1% | +9.2% | -62.7% | +35.4% | +39.8% | |
| – | -0.7% | +38.8% | -44.1% | – | -172.0% | – | -133.4% | +559.0% | – | -628.2% | -96.3% | |
| – | – | +18.0% | +17.9% | +15.9% | +17.1% | +14.3% | +0.7% | +12.2% | -22.5% | +47.7% | +10.5% | |
| – | – | -7.0% | +2.8% | +46.7% | +110.5% | -45.8% | +41.3% | +103.9% | -73.0% | +30.2% | -18.5% | |
| – | +241.3% | -33.6% | +16.1% | +25.1% | +188.3% | -46.1% | +21.5% | +141.8% | -68.2% | +48.3% | -14.1% | |
| – | – | – | – | +153.8% | -141.1% | – | -44.2% | -495.1% | – | -240.7% | – | |
| – | – | +20.8% | +97.4% | -2.2% | -19.8% | +28.4% | +43.1% | -34.1% | +0.3% | +14.4% | +44.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.